There is a growing demand to realize low-cost miniaturized point-of-care testing diagnostic devices capable of performing many analytical assays. To fabricate such devices, three-dimensional printing (3DP)-based fabrication techniques provide a turnkey approach with marked precision and accuracy. Here, a 3DP fabrication technique was successfully utilized to fabricate closed bipolar electrode-based electrochemiluminescence (ECL) devices using conductive graphene filament. Furthermore, using these ECL devices, Ru(bpy)(3)(2+)/TPrA- and luminol/H2O2-based electrochemistry was leveraged to sense dopamine and choline respectively. For ECL signal capture, two distinct approaches were used, first a smartphone-based miniaturized platform and the second with a photomultiplier tube embedded with the internet of things technology. Choline sensing led to a linear range 5-700 mu M and 30-700 mu M with a limit of detection (LOD) of 1.25 mu M (R-2 = 0.98, N = 3) and 3.27 mu M (R-2 = 0.97, N = 3). Furthermore, dopamine sensing was achieved in a linear range 0.5-100 mu M with an LOD = 2 mu M (R-2 = 0.99, N = 3) and LOD = 0.33 mu M (R-2 = 0.98, N = 3). Overall, the fabricated devices have the potential to be utilized effectively in real-time applications such as point-of-care testing.